机构地区:[1]福建省龙岩市第一医院福建医科大学附属龙岩第一医院检验科,364000
出 处:《中华检验医学杂志》2016年第4期251-255,共5页Chinese Journal of Laboratory Medicine
基 金:福建省卫生厅青年科研资助课题(2013-2-149)
摘 要:目的探讨全血可溶性白细胞分化抗原14-亚型(sCDl4-ST)在儿童脓毒症早期诊断和疗效监测中的临床意义。方法病例对照研究。检测2013年8月至2015年3月期间福建省龙岩市第一医院儿童重症监护病房(PICU)237例脓毒症[即感染性全身炎症反应综合征(SIRS),其中细菌性SIRS120例,非细菌性SIRS117例]、89例非感染性SIRS,156名体检健康患儿sCDl4-ST、WBC、CRP、PCT、APACHE—II水平,观察脓毒症患儿治疗前后各指标动态变化情况及相关性。受试者工作曲线(ROC)分析sCDl4.ST的脓毒症诊断价值。结果脓毒症组sCDl4-ST水平[643.47(596.47—690.46)ng/L]显著高于非感染性SIRS组[246.94(234.85~259.03)ng/L]和健康对照组[151.00(142.79~159.22)ng/L](x2=121.850、325.663,P〈0.01)。细菌性SIRS组sCDl4-ST水平[606.17(542.71—669.63)ng/L]与非细菌性SIRS组[679.83(610.37~747.29)ng,/L]比差异无统计学意义(X2=0.854,P=0.335),与健康对照组比差异有统计学意义(X。=326.228,P〈0.01)。117例细菌性SIRS中有80例血培养阳性,sCDl4-ST在革兰阳性菌组[641.07(553.82~728.31)ng/L]与革兰阴性菌组[750.00(597.10—902.89)ns/L]间差异无统计学意义(X。=1.12,P=0.29),但均明显高于健康对照组(x。=117.46、155.846,P〈0.01);sCDl4-ST、WBC、CRP、PCT、APACHE—II评分在治疗前、后均明显下降(x1=44.569、113.337、63.986、100.055、51.015,P〈0.01),治疗前sCDl4-ST与CRP、APACHE.II评分呈显著正相关(R=0.553、0.807,P〈0.01),与WBC、PCT则无相关性(R=0.187、-0.042,P〉0.05)。脓毒症患儿sCDl4-ST的ROC曲线下面积为0.901,与WBC、CRP曲线下面积(ROC.AUC=0.875、0.836)比较,差异有统计学意义(z=-8.172、-11.398、8.625,P均〈0.01),sCDl4.ST的敏感度、特异度分�Objective To explore the clinical sepsis and monitoring the treatment effects. Methods significance of sCD14-ST in diagnosing children Case-control study. Patients were recruited by Longyan First Hospital from August 2013 to March 2015. The sCD14-ST, WBC, CRP, PCT and APACHE- I1 levels were measured in 237 septic children (infectious SIRS, including 120 bacterial and 117 nonbacterial SIRS) , 89 non-infectious SIRS and 156 healthy children. The changes and the correlation of the five indicators in septic children before and after treatment was compared~ The diagnosis value of sCD14- ST in sepsis by the receiver operationg characteristic curves (ROC) was analyzed. Results The sCD14-ST level in septic children [ 643.47 ( 596.47 - 690.46 ) ng/L ] was higher than that in non-infectious SIRS [ 246.94 (234.85 - 259~ 03 ) ng/L ] and healthy control [ 151.00 ( 142~ 79 - 159.22 ) ng/L ] ( ~2 = 121. 850, 325. 663, P 〈 0. 01 ). The whole blood level of sCD14-ST in bacterial sepsis [ 606.17 ( 542.71 - 669.63 ) ng/L] and non-bacterial sepsis [ 679~ 83 (610~ 37 - 747.29 ) ng/L ] were no significance ( ~2 = 0. 854, P = 0. 335 ), while compared with the control group, they had significant differences ( X2 = 326. 228, P 〈 0. 01 ) ~ Totally 80 blood culture samples were positive in 117 bacterial septic children, and the sCD14-ST level was not significant between Gram positive bacteria infection and [ 641.07 (553.82 - 728.31 ) ng/L ] Gram negative bacteria infection[ 750.00 ( 597.10 - 902.89 ) ng/L ] ( X2 = 1.12, P = 0. 29 ), but the sCD14-ST level in blood culture positive children was significantly higher than healthy controls (chi-square = 117.46, 155. 846, P 〈 0. O1 ). sCD14-ST, WBC, CRP, PCT, APACHE- II score before and after treatment were all significantly decreased ( X2 =44. 569, 113. 337, 63. 986, 100. 055, 51. 015, P 〈 0. 01 ). The sCD14-ST was significantly positively related withCRP and APACHE-II score before treatment, but there were no correlation wit
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...